Shortages of essential medicines for pediatric cancer patients threaten outcomes
Shortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients and hospitals …
Home » Medications »
FDA Approves Herceptin Hylecta
South San Francisco, CA — February 28, 2019 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
Why a common antibiotic treating diarrhea is failing
In the world of superbugs (bacteria that has grown resistant to antibiotics) Clostridioides difficile, a bacterium that causes diarrhea and …
FDA Approves Gloperba
WOBURN, Mass.–(BUSINESS WIRE)–February 26, 2019 ROMEG Therapeutics, an innovative drug development company focused on alternative formulations to better meet clinical …
Apellis Pharmaceuticals’ APL-2 Receives Fast Track Designation from the FDA for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
WALTHAM Mass., and CRESTWOOD, Ky., Feb. 11, 2019 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused …
Insurance rules make it harder to treat opioid use disorder
Insurance industry cost-control measures may be worsening the nation’s opioid epidemic by limiting access to a key medication that treats …
FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
HORSHAM, Pa., Jan. 28, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food …
MediciNova Announces Initiation of Enrollment in a Clinical Trial of MN-166 (ibudilast) in Glioblastoma
LA JOLLA, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market …